Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
- 18 December 2024 - 1 mins read
The aim of the study is to compare in an exploratory fashion the efficacy on progression-free survival of lanreotide in addition to non steroidal anti androgens and LHRH-a in non metastatic castrate resistant prostate cancer patients.
18 December 2024
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
18 December 2024
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
18 December 2024
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
18 December 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
18 December 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
18 December 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
18 December 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Study
18 December 2024
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
18 December 2024
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
18 December 2024
1 mins read